Concepedia

Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials

Stephen R. Marder, Robert D. McQuade, Elyse Stock, Stephen Kaplita, Ronald N. Marcus, Allan Z. Safferman, Anutosh Ranjan Saha, Mirza W. Ali, Taro Iwamoto

Schizophrenia Research · 2003 · 469 citations · 32 references

DOI

Concepts

References

32

Psychopharmacology: The Fourth Generation of Progress

James J. Brophy · JAMA · 1995 · 1.6K citations

, , +8

Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors

Kevin D. Burris, Thaddeus F. Molski, Cen Xu et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 922 citations

, , +16

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

Gary D. Tollefson, Charles M. Beasley, P.V. Tran et al. · American Journal of Psychiatry · 1997 · 901 citations

, , +17

The unhealthy lifestyle of people with schizophrenia

Stephen Brown, Jon Birtwistle, Liane S. Roe · Psychological Medicine · 1999 · 885 citations

, , +12

Olanzapine versus Placebo and Haloperidol

Charles M. Beasley, Gary D. Tollefson, P. Tran et al. · Neuropsychopharmacology · 1996 · 787 citations

, , +12